Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
28.00
1.31 (4.91%)
At close: Aug 15, 2025, 3:59 PM
28.04
0.12%
After-hours: Aug 15, 2025, 07:58 PM EDT
Moderna Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 142M | 107M | 956M | 1.85B | 221M | 167M | 2.81B | 1.83B | 344M | 1.84B | 5.15B | 3.22B | 4.57B | 5.94B | 6.95B | 4.83B | 4.21B | 1.74B |
Cost of Revenue | 119M | 90M | 739M | 514M | 115M | 96M | 929M | 2.24B | 731M | 792M | 1.92B | 1.1B | 1.38B | 1.02B | 952M | 722M | 750M | 193M |
Gross Profit | 23M | 17M | 217M | 1.34B | 106M | 71M | 1.88B | -410M | -387M | 1.05B | 3.23B | 2.12B | 3.19B | 4.92B | 6B | 4.11B | 3.46B | 1.55B |
Operating Income | -907M | -1.05B | -1.25B | -70M | -1.36B | -1.27B | 6M | -2.01B | -1.87B | -366M | 1.58B | 1.17B | 2.45B | 4.23B | 5.41B | 3.56B | 3.06B | 1.27B |
Interest Income | 81M | 90M | 91M | 103M | 111M | 120M | 103M | 105M | 104M | 109M | 87M | 58M | 40M | 15M | 7M | 4M | 3M | 4M |
Pretax Income | -818M | -964M | -1.18B | 21M | -1.28B | -1.17B | 70M | -1.96B | -1.75B | -305M | 1.66B | 1.22B | 2.47B | 4.23B | 5.41B | 3.55B | 3.06B | 1.26B |
Net Income | -825M | -971M | -1.12B | 13M | -1.28B | -1.18B | 217M | -3.63B | -1.38B | 79M | 1.47B | 1.04B | 2.2B | 3.66B | 4.87B | 3.33B | 2.78B | 1.22B |
Selling & General & Admin | 230M | 212M | 351M | 281M | 268M | 274M | 470M | 442M | 332M | 305M | 375M | 278M | 211M | 268M | 201M | 168M | 121M | 77M |
Research & Development | 700M | 856M | 1.12B | 1.14B | 1.22B | 1.03B | 1.41B | 1.16B | 1.15B | 1.13B | 1.21B | 820M | 710M | 554M | 648M | 521M | 421M | 401M |
Other Expenses | n/a | -1M | -10M | -7M | -20M | 36M | 2M | n/a | n/a | -24M | 65M | -144M | -183M | -126M | -262M | -140M | -139M | -194M |
Operating Expenses | 930M | 1.07B | 1.46B | 1.41B | 1.47B | 1.34B | 1.88B | 1.6B | 1.48B | 1.41B | 1.65B | 954M | 738M | 696M | 587M | 549M | 403M | 284M |
Interest Expense | n/a | 1M | 6M | 6M | 6M | 6M | 6M | 10M | 13M | 9M | 10M | 8M | 5M | 6M | 6M | 4M | 5M | 3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 204M | n/a | n/a | n/a | 121M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.05B | 1.16B | 2.2B | 1.93B | 1.58B | 1.43B | 2.81B | 3.84B | 2.21B | 2.2B | 3.57B | 2.05B | 2.12B | 1.71B | 1.54B | 1.27B | 1.15B | 477M |
Income Tax Expense | 7M | 7M | -64M | 8M | n/a | 10M | -147M | 1.67B | -369M | -384M | 190M | 174M | 277M | 572M | 542M | 219M | 283M | 39M |
Shares Outstanding (Basic) | 388M | 386M | 385M | 385M | 384M | 382M | 381M | 381M | 381M | 386M | 385M | 390M | 396M | 402M | 405M | 404M | 402M | 400M |
Shares Outstanding (Diluted) | 388M | 386M | 385M | 399M | 384M | 382M | 395M | 381M | 381M | 405M | 405M | 412M | 419M | 426M | 431M | 434M | 431M | 430M |
EPS (Basic) | -2.13 | -2.52 | -2.91 | 0.03 | -3.33 | -3.08 | 0.57 | -9.53 | -3.62 | 0.20 | 3.81 | 2.67 | 5.55 | 9.09 | 12.03 | 8.27 | 6.93 | 3.05 |
EPS (Diluted) | -2.13 | -2.52 | -2.91 | 0.03 | -3.33 | -3.08 | 0.55 | -9.53 | -3.62 | 0.20 | 3.62 | 2.53 | 5.24 | 8.58 | 11.29 | 7.70 | 6.46 | 2.84 |
EBITDA | -760M | -924M | -1.12B | 79M | -1.23B | -1.12B | 278M | -1.7B | -1.65B | -218M | 1.75B | 1.34B | 2.56B | 4.31B | 5.49B | 3.63B | 3.14B | 1.28B |
EBIT | -817M | -963M | -1.18B | 27M | -1.27B | -1.16B | 76M | -1.95B | -1.74B | -296M | 1.67B | 1.23B | 2.48B | 4.24B | 5.42B | 3.56B | 3.07B | 1.26B |
Depreciation & Amortization | 57M | 39M | 60M | 52M | 41M | 36M | 202M | 249M | 90M | 78M | 80M | 113M | 76M | 79M | 78M | 70M | 69M | 15M |